Cite
Sutton P, Evans J, Jones R, et al. Proteomic analysis to identify biomarkers in the primary tumour that predict response to neoadjuvant chemotherapy in liver metastases. Lancet. 2015;385:S95doi: 10.1016/S0140-6736(15)60410-X.
Sutton, P., Evans, J., Jones, R., Malik, H., Vimalachandran, D., Palmer, D., Goldring, C., & Kitteringham, N. (2015). Proteomic analysis to identify biomarkers in the primary tumour that predict response to neoadjuvant chemotherapy in liver metastases. Lancet (London, England), 385S95. https://doi.org/10.1016/S0140-6736(15)60410-X
Sutton, Paul, et al. "Proteomic analysis to identify biomarkers in the primary tumour that predict response to neoadjuvant chemotherapy in liver metastases." Lancet (London, England) vol. 385 (2015): S95. doi: https://doi.org/10.1016/S0140-6736(15)60410-X
Sutton P, Evans J, Jones R, Malik H, Vimalachandran D, Palmer D, Goldring C, Kitteringham N. Proteomic analysis to identify biomarkers in the primary tumour that predict response to neoadjuvant chemotherapy in liver metastases. Lancet. 2015 Feb 26;385:S95. doi: 10.1016/S0140-6736(15)60410-X. PMID: 26312918.
Copy
Download .nbib